hae-20200528

0000313143-20-000031.txt : 20200528 0000313143-20-000031.hdr.sgml : 20200528 20200528162345 ACCESSION NUMBER: 0000313143-20-000031 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20200528 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200528 DATE AS OF CHANGE: 20200528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0328 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 20921374 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 8-K 1 hae-20200528.htm 8-K hae-20200528

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 28, 2020

HAEMONETICS CORPORATION

(Exact name of registrant as specified in its charter)

Massachusetts

001-14041

04-2882273

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

125 Summer Street

Boston, MA 02110

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: 781-848-7100

(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $.01 par value per share

HAE

New York Stock Exchange


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company
☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On May 28, 2020, Haemonetics Corporation (the “Company”) and its wholly-owned subsidiary, Global Med Technologies, Inc., entered into an asset purchase agreement (the “Agreement”) with GPI Group (“GPI”), pursuant to which GPI will acquire the intellectual property, customer contracts and certain other assets relating to the Company’s ElDorado Donor^®, Hemasphere^®, Donor Doc^®, Donor Doc Phlebotomy^®, eDonor^®, DonorSpace^®, Surround^™ and SafeTrace^® software products within the Company's Blood Center business unit (collectively, the “Asset Transfer”).

Under the terms of the Agreement, GPI will pay the Company $14 million in upfront cash at the closing of the Asset Transfer and up to $14 million in additional consideration contingent on achievement of commercial milestones over the twelve month period immediately following the closing of the transaction. The blood donor management software subject to the Asset Transfer represents approximately $11.3 million of the Company's fiscal 2020 revenue. The transaction is expected to close in the second quarter of calendar 2020, subject to the satisfaction of customary closing conditions.

A copy of the Company’s press release announcing the Asset Transfer is attached to this Current Report on Form 8-K as Exhibit 99.1.

Cautionary Note Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements about the Asset Transfer, including, but not limited to, statements related to the anticipated closing of the Asset Transfer, the estimated cash proceeds to be received and other statements that are not historical facts. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company’s current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risks that the Asset Transfer may not close in a timely manner or at all and that the Company may not realize the anticipated benefits of the Asset Transfer or the Asset Transfer may have an unanticipated impact, including from non-achievement of any commercial milestone required for the Company to receive all of part of the additional contingent consideration. Investors should consult the Company's filings with the Securities and Exchange Commission (including the Company’s reports on Forms 10-K, 10-Q and 8-K) for information about additional risks and uncertainties that could cause the Company’s actual results to differ materially from these forward-looking statements. The Company undertakes no duty or obligation to update any forward-looking statements contained in this Current Report on Form 8-K as a result of new information, future events or changes in its expectations.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits


Exhibit Number						Description
99.1						Press release dated May 28, 2020.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HAEMONETICS CORPORATION

May 28, 2020

By:

/s/ Christopher A. Simon

Name:

Christopher A. Simon

Title:

President and Chief Executive Officer

EX-99.1 2 form8-kexhibitpressrel.htm EX-99.1 Document

Exhibit 99.1

FOR IMMEDIATE RELEASE


Investor Contact: Olga Guyette, Director-Investor Relations (781) 356-9763 olga.guyette@haemonetics.com						Media Contact: Carla Burigatto, VP-Communications (781) 348-7263 carla.burigatto@haemonetics.com

HAEMONETICS ANNOUNCES SALE OF U.S. BLOOD DONOR MANAGEMENT SOFTWARE SOLUTION ASSETS TO THE GPI GROUP

BOSTON, MA, May 28, 2020 - Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to sell certain blood donor management software solution assets within its Blood Center business unit to the GPI Group (GPI: IM). GPI is a leading company in providing IT Solutions supporting Healthcare and Social Services, listed on the MTA market of Borsa Italiana.

“We are committed to reshaping our portfolio for sustainable growth and this sale will enable us to focus on our core capabilities while delivering quality products and services where we bring distinct value,” said Chad Nikel, Haemonetics’ President, Global Blood Center. “We will continue to invest across our business, execute our customer-centric strategies to strengthen our trajectory and develop innovative medical technologies that meaningfully advance healthcare.”

Fausto Manzana, GPI President and CEO, said, “Our priority is to deliver state-of-the-art technology solutions with a comprehensive approach to cover all aspects of blood transfusion for maximum traceability, patient safety and high client satisfaction. GPI will merge the acquired assets with its U.S.-based Hemasoft operations to strengthen the Hemasoft presence in the U.S. by offering a complete portfolio of software and services.”

Under the terms of the transaction, Haemonetics and its subsidiary Global Med Technologies, Inc. will transfer the intellectual property, customer contracts and certain other assets relating to its ElDorado Donor®, Hemasphere ®, Donor Doc®, Donor Doc Phlebotomy®, eDonor®, DonorSpace®, Surround™ and SafeTrace® software products to GPI. These products are sold predominantly in the U.S. and provide a range of solutions to optimize blood donor collection centers’ blood drive planning, donor recruitment and retention, blood collection, component manufacturing and distribution. The GPI Group business in the U.S. is managed through its subsidiary Hemasoft. Hemasoft is a U.S. company providing specialized web-based software solutions for blood donor centers, blood banks, transfusion services, cell therapy labs and tissue banks.

This transaction is expected to close in the second quarter of calendar 2020, subject to the satisfaction of customary closing conditions.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Haemonetics Cautionary Statement Regarding Forward-Looking Information

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements in this press release may include, without limitation, statements regarding the consummation of the proposed transactions described in this press release, including the estimated cash proceeds and any additional contingent consideration, and statements regarding Haemonetics’ strategies, positioning, resources, capabilities, and expectations for future performance. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon Haemonetics’ current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, any event, changes or other circumstance that delays or gives rise to termination of the proposed transaction, including the failure of the parties to satisfy conditions to completion of the transaction; the failure to realize the anticipated benefits of the transaction or the transaction having an unanticipated impact, including from non-achievement of any commercial milestone required to receive all or part of the additional contingent consideration; Haemonetics’ ability to predict accurately the demand for its products and products under development and to develop strategies to address its markets successfully and the impact of competitive products and pricing and technical innovations that could render products marketed or under development by Haemonetics obsolete. These and other factors are identified and described in more detail in Haemonetics’ filings with the SEC. Haemonetics does not undertake to update these forward-looking statements.

EX-101.SCH 3 hae-20200528.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 hae-20200528_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 hae-20200528_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 hae-20200528_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Cover [Abstract] Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Amendment Flag Amendment Flag Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 7 hae-20200528_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 image01.jpg begin 644 image01.jpg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end XML 9 hae-20200528_htm.xml IDEA: XBRL DOCUMENT 0000313143 2020-05-28 2020-05-28 0000313143 false 8-K 2020-05-28 HAEMONETICS CORPORATION MA 001-14041 04-2882273 125 Summer Street Boston MA 02110 781 848-7100 false false false false Common stock, $.01 par value per share HAE NYSE false XML 10 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	May 28, 2020
Cover [Abstract]
Document Type	8-K
Document Period End Date	May 28, 2020
Entity Registrant Name	HAEMONETICS CORPORATION
Entity Central Index Key	0000313143
Amendment Flag	false
Entity Incorporation, State or Country Code	MA
Entity File Number	001-14041
Entity Tax Identification Number	04-2882273
Entity Address, Address Line One	125 Summer Street
Entity Address, City or Town	Boston
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02110
City Area Code	781
Local Phone Number	848-7100
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common stock, $.01 par value per share
Trading Symbol	HAE
Security Exchange Name	NYSE
Entity Emerging Growth Company	false

EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end ZIP 13 0000313143-20-000031-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000313143-20-000031-xbrl.zip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ilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Document and Entity Information Sheet http://www.haemonetics.com/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports hae-20200528.htm form8-kexhibitpressrel.htm hae-20200528.xsd hae-20200528_cal.xml hae-20200528_def.xml hae-20200528_lab.xml hae-20200528_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "hae-20200528.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "hae-20200528_cal.xml" ] }, "definitionLink": { "local": [ "hae-20200528_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "hae-20200528.htm" ] }, "labelLink": { "local": [ "hae-20200528_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "hae-20200528_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "hae-20200528.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hae", "nsuri": "http://www.haemonetics.com/20200528", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hae-20200528.htm", "contextRef": "i67404e8a0ebf49afb8a5ed37fd51635d_D20200528-20200528", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document and Entity Information", "role": "http://www.haemonetics.com/role/DocumentandEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hae-20200528.htm", "contextRef": "i67404e8a0ebf49afb8a5ed37fd51635d_D20200528-20200528", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.haemonetics.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" }